Arranta Bio has acquired microbiome process development and clinical contract manufacturer, Captozyme, and with it established a Center of Excellence for process and analytical development and early clinical supply for microbiome clients. Captozyme’s team and facilities in Gainesville, FL have been transferred to Arranta.   Formed in 2009, Captozyme has been a provider of development services to microbiome pioneers with a team that has developed processes for over 125 different species and 80 di...